ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study of IRESSA in Relapsed and Refractory Small Cell Lung Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00298688
Recruitment Status : Completed
First Posted : March 3, 2006
Last Update Posted : June 12, 2008
Sponsor:
Information provided by:
AstraZeneca

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : No date given
  Actual Study Completion Date : March 2007